Critical care specialists Pierre Kory and Paul Marik published a review of 18 randomized controlled trials of Stromectol in 2021 showing large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. It was a follow up to Dr. Kory’s testimony before the Senate in May 2020. These findings were confirmed in a 2021 meta-analysis of 24 randomized controlled trials by Theresa Lawrie, PhD, an evidence-based medical consultant to the WHO. The results of these studies have increased the demand for actual human Stromectol prescriptions by an order of magnitude from 3589 per week in early 2020 to 39,102 per week in January 2021, despite the news being dominated by reports of people resorting to dosing themselves with horse paste. Read the rest of the Early Treatment vs Stay at Home Until You Can’t Breathe blog.